Skip to main content
Top
Published in: Diabetologia 10/2021

Open Access 01-10-2021 | Stroke | Article

Retinal arteriolar tortuosity and fractal dimension are associated with long-term cardiovascular outcomes in people with type 2 diabetes

Authors: Emmanuel Sandoval-Garcia, Stela McLachlan, Anna H. Price, Thomas J. MacGillivray, Mark W. J. Strachan, James F. Wilson, Jackie F. Price

Published in: Diabetologia | Issue 10/2021

Login to get access

Abstract

Aims/hypothesis

Our aim was to determine whether quantitative retinal traits in people with type 2 diabetes are independently associated with incident major cardiovascular events including CHD and stroke.

Methods

A total of 1066 men and women with type 2 diabetes, aged 65–74 years, were followed up over 8 years in the population-based Edinburgh Type 2 Diabetes Study. Using retinal photographs taken at baseline and specialist software, a number of quantitative retinal traits were measured, including arteriolar and venular widths and tortuosity as well as fractal dimension (a measure of the branching pattern complexity of the retinal vasculature network). Incident CHD events occurring during follow-up included fatal and non-fatal myocardial infarction, first episodes of angina and coronary interventions for CHD. Incident cerebrovascular events included fatal and non-fatal stroke or transient ischaemic attack. Cox proportional hazard regression analyses were performed to identify the association of the retinal traits with cardiovascular events in the population with retinal data available (n = 1028).

Results

A total of 200 participants had an incident cardiovascular event (139 CHD and 61 cerebrovascular events). Following adjustment for age and sex, arteriolar tortuosity and fractal dimension were associated with cerebrovascular events (HR 1.27 [95% CI 1.02, 1.58] and HR 0.74 [95% CI 0.57, 0.95], respectively), including with stroke alone (HR 1.30 [95% CI 1.01, 1.66] and HR 0.73 [95% CI 0.56, 0.97], respectively). These associations persisted after further adjustment for established cardiovascular risk factors (HR 1.26 [95% CI 1.01, 1.58] and HR 0.73 [95% CI 0.56, 0.94], respectively). Associations generally reduced in strength after a final adjustment for the presence of diabetic retinopathy, but the association of fractal dimension with incident cerebrovascular events and stroke retained statistical significance (HR 0.73 [95% CI 0.57, 0.95] and HR 0.72 [95% CI 0.54, 0.97], respectively). Associations of retinal traits with CHD were generally weak and showed no evidence of statistical significance.

Conclusions/interpretation

Arteriolar tortuosity and fractal dimension were associated with incident cerebrovascular events, independent of a wide range of traditional cardiovascular risk factors including diabetic retinopathy. These findings suggest potential for measurements of early retinal vasculature change to aid in the identification of people with type 2 diabetes who are at increased risk from stroke.

Graphical abstract

Appendix
Available only for authorised users
Literature
3.
go back to reference Kengne AP, Patel A, Colagiuri S et al (2010) The Framingham and UK Prospective Diabetes Study (UKPDS) risk equations do not reliably estimate the probability of cardiovascular events in a large ethnically diverse sample of patients with diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron-MR Controlled Evaluation (ADVANCE) study. Diabetologia 53(5):821–831. https://doi.org/10.1007/s00125-010-1681-4CrossRefPubMed Kengne AP, Patel A, Colagiuri S et al (2010) The Framingham and UK Prospective Diabetes Study (UKPDS) risk equations do not reliably estimate the probability of cardiovascular events in a large ethnically diverse sample of patients with diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron-MR Controlled Evaluation (ADVANCE) study. Diabetologia 53(5):821–831. https://​doi.​org/​10.​1007/​s00125-010-1681-4CrossRefPubMed
16.
go back to reference Trucco E, Giachetti A, Ballerini L, Relan D, Cavinato A, MacGillivray T (2015) Morphometric measurements of the retinal vasculature in fundus images with VAMPIRE. In: Lim J-H, Ong S-H, Xiong W (eds) Biomedical image understanding. John Wiley & Sons, Inc, Hoboken, NJ, pp 91–112. https://doi.org/10.1002/9781118715321.ch3CrossRef Trucco E, Giachetti A, Ballerini L, Relan D, Cavinato A, MacGillivray T (2015) Morphometric measurements of the retinal vasculature in fundus images with VAMPIRE. In: Lim J-H, Ong S-H, Xiong W (eds) Biomedical image understanding. John Wiley & Sons, Inc, Hoboken, NJ, pp 91–112. https://​doi.​org/​10.​1002/​9781118715321.​ch3CrossRef
Metadata
Title
Retinal arteriolar tortuosity and fractal dimension are associated with long-term cardiovascular outcomes in people with type 2 diabetes
Authors
Emmanuel Sandoval-Garcia
Stela McLachlan
Anna H. Price
Thomas J. MacGillivray
Mark W. J. Strachan
James F. Wilson
Jackie F. Price
Publication date
01-10-2021
Publisher
Springer Berlin Heidelberg
Published in
Diabetologia / Issue 10/2021
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-021-05499-z

Other articles of this Issue 10/2021

Diabetologia 10/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.